HOME >> BIOLOGY >> NEWS
Research to create lung-cancer blood tests receives $3.4M in Pennsylvania tobacco settlement funds

(PHILADELPHIA Thursday, March 11, 2004) A team of researchers from The Wistar Institute, Fox Chase Cancer Center, and the University of Pennsylvania has been awarded $3.4 million to pursue development of blood tests for lung cancer. The need for such tests is great lung cancer kills more Americans by far than any other form of cancer, according to statistics compiled by the American Cancer Society.

As with most cancers, treatment for lung cancer is much more effective when the cancer is detected at an early stage. The Wistar-led research team will use a systems-biology approach primarily applying the recently developed tools of proteomics and genomics to find proteins and genes in the blood that indicate the presence of early lung cancer. They will then develop blood tests based on this information that could aid many people by detecting their cancers at an earlier stage than is currently possible.

"This funding allows us to bring together an expert team of basic scientists and clinicians to tackle a critical medical problem," said David W. Speicher, Ph.D., professor and co-leader of the molecular and cellular oncogenesis program at The Wistar Institute and principal investigator on the lung-cancer project. "Our aim is to develop powerful new diagnostic tools that should help save lives through earlier cancer detection."

The announcement of the grant was made today by Pennsylvania Health Secretary Dr. Calvin Johnson on behalf of Governor Edward G. Rendell. The grant was one of five health research grants totaling $22.5 million funded from Pennsylvania's share of the national tobacco settlement.

These non-formula grants competitive grants based on research priorities and not dictated by a formula will develop Centers of Excellence to reduce disparities in lung disease and pregnancy outcomes. "Center of Excellence" is a special designation given to medical or educational institutions conducting concentrated, s
'"/>

Contact: Franklin Hoke
hoke@wistar.upenn.edu
215-898-3716
The Wistar Institute
12-Mar-2004


Page: 1 2 3

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
4. Researchers identify protein promoting vascular tumor growth
5. Researchers devise potent new tools to curb ivory poaching
6. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
7. Researchers ID chlorophyll-regulating gene
8. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
9. Research suggests new avenue for stopping, preventing colon cancer
10. Researchers develop fast track way to discover how cells are regulated
11. Research on carbohydrate metabolism receives historical recognition

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: